$Novo-Nordisk A/S(NVO)$ view o

$Novo-Nordisk A/S(NVO)$ view order details.@Trade Feed Decoder

NVO

07-29 23:58

USNovo-Nordisk A/S

Side	Price \| Filled	Realized P&L
Buy Open	53.65 60	-- Closed

Novo-Nordisk A/S

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
07-30
Trade Feed Decoder
This Novo-Nordisk (NVO) trade achieved a modest +1.42% gain, suggesting efficient short-term execution given the stock's typical low volatility in the healthcare sector. The timing (03:43:20 local) aligns with potential pre-market positioning, possibly anticipating news flow or sector momentum. As a pharmaceutical leader in diabetes treatments, NVO's fundamental stability likely supported the trade's controlled risk parameters. The profit margin indicates disciplined exit criteria, though the absence of position size data limits full risk/reward assessment. Traders might analyze whether this aligns with momentum strategies or news-driven plays common in pharma. The trade exemplifies tactical entries in blue-chip healthcare stocks, balancing moderate returns with sector-specific catalysts.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":461871836963264,"tweetId":"461871836963264","gmtCreate":1753804822788,"gmtModify":1753810496585,"author":{"id":4188094289216912,"idStr":"4188094289216912","authorId":4188094289216912,"authorIdStr":"4188094289216912","name":"Lambert LI","avatar":"https://community-static.tradeup.com/news/f27979f2a8ce45baa6c65835dc40fbb4","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":83,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":80,"starInvestorOrderShareNum":321,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":-17.75,"showRor":true,"investmentPhilosophy":"所有披露均仅为个人记录，不代表任何建议，参考请谨慎","winRationPercentage":60.839161,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Novo-Nordisk A/S(NVO)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":26,"commentSize":1,"repostSize":14,"favoriteSize":0,"link":"https://ttm.financial/post/461871836963264","repostId":0,"isVote":1,"tweetType":1,"viewCount":923,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4188094289216912","orderId":"39964373301089280","kind":"TRADE","symbol":"NVO","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/NVO","symbolName":"Novo-Nordisk A/S","market":"US","action":"BUY","currency":"USD","symbolLogo":"https://static.tigerbbs.com/4454e2be594d73a2a7bfa9c42bfb69f7","showFilledQuantity":true,"nameCN":"Novo-Nordisk A/S","orderType":"LMT","filledQuantityFinal":60,"avgFillPrice":53.65,"createTime":1753804727,"filledQuantity":"60","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Novo-Nordisk A/S","contractExtraDescription":"NVO","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":0.0142},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":461897695035840,"commentId":"461897695035840","gmtCreate":1753811135793,"gmtModify":1753811485491,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":461871836963264,"objectIdStr":"461871836963264","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"This Novo-Nordisk (NVO) trade achieved a modest +1.42% gain, suggesting efficient short-term execution given the stock's typical low volatility in the healthcare sector. The timing (03:43:20 local) aligns with potential pre-market positioning, possibly anticipating news flow or sector momentum. As a pharmaceutical leader in diabetes treatments, NVO's fundamental stability likely supported the trade's controlled risk parameters. The profit margin indicates disciplined exit criteria, though the absence of position size data limits full risk/reward assessment. Traders might analyze whether this aligns with momentum strategies or news-driven plays common in pharma. The trade exemplifies tactical entries in blue-chip healthcare stocks, balancing moderate returns with sector-specific catalysts.","text":"This Novo-Nordisk (NVO) trade achieved a modest +1.42% gain, suggesting efficient short-term execution given the stock's typical low volatility in the healthcare sector. The timing (03:43:20 local) aligns with potential pre-market positioning, possibly anticipating news flow or sector momentum. As a pharmaceutical leader in diabetes treatments, NVO's fundamental stability likely supported the trade's controlled risk parameters. The profit margin indicates disciplined exit criteria, though the absence of position size data limits full risk/reward assessment. Traders might analyze whether this aligns with momentum strategies or news-driven plays common in pharma. The trade exemplifies tactical entries in blue-chip healthcare stocks, balancing moderate returns with sector-specific catalysts.","html":"This Novo-Nordisk (NVO) trade achieved a modest +1.42% gain, suggesting efficient short-term execution given the stock's typical low volatility in the healthcare sector. The timing (03:43:20 local) aligns with potential pre-market positioning, possibly anticipating news flow or sector momentum. As a pharmaceutical leader in diabetes treatments, NVO's fundamental stability likely supported the trade's controlled risk parameters. The profit margin indicates disciplined exit criteria, though the absence of position size data limits full risk/reward assessment. Traders might analyze whether this aligns with momentum strategies or news-driven plays common in pharma. The trade exemplifies tactical entries in blue-chip healthcare stocks, balancing moderate returns with sector-specific catalysts.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/461871836963264"}